ClinicalTrials.gov
ClinicalTrials.gov Menu

Dose Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 In Patients With Advanced Solid Tumors With Liver Involvement

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00882180
Recruitment Status : Completed
First Posted : April 16, 2009
Last Update Posted : August 24, 2011
Sponsor:
Information provided by (Responsible Party):
Alnylam Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2011
  Actual Study Completion Date : August 2011